Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-160,062 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-256,862 Reduced 61.61%
160,062 $2.81 Million
Q2 2021

Aug 13, 2021

BUY
N/A
19,979 Added 5.03%
416,924 $4.04 Million
Q1 2021

May 17, 2021

BUY
N/A
372,463 Added 1521.37%
396,945 $4.26 Million
Q4 2020

Feb 16, 2021

BUY
N/A
24,482 New
24,482 $360,000
Q2 2019

Aug 14, 2019

SELL
N/A
-110,282 Closed
0 $0
Q1 2019

May 14, 2019

BUY
N/A
110,282 New
110,282 $73,000

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.